5/2
10:29 am
tech
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
5/2
10:26 am
tech
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
08:11 am
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
5/1
01:20 pm
tech
Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate [Yahoo! Finance]
5/1
11:12 am
tech
Bio-Techne beats third-quarter estimates on improving demand for biotech products [Reuters]
Low
Report
Bio-Techne beats third-quarter estimates on improving demand for biotech products [Reuters]
5/1
07:41 am
tech
Bio-Techne beats third-quarter estimates on improving demand for biotech products [Yahoo! Finance]
Medium
Report
Bio-Techne beats third-quarter estimates on improving demand for biotech products [Yahoo! Finance]
5/1
06:42 am
tech
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS [Yahoo! Finance]
High
Report
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS [Yahoo! Finance]
5/1
06:30 am
tech
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
High
Report
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
5/1
06:30 am
tech
BIO-TECHNE DECLARES DIVIDEND
High
Report
BIO-TECHNE DECLARES DIVIDEND
4/30
07:10 am
tech
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS [Yahoo! Finance]
Low
Report
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS [Yahoo! Finance]
4/30
07:00 am
tech
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
Low
Report
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
4/29
07:13 am
tech
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC [Yahoo! Finance]
Low
Report
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC [Yahoo! Finance]
4/29
07:00 am
tech
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
Low
Report
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
4/26
07:08 am
tech
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY [Yahoo! Finance]
Low
Report
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY [Yahoo! Finance]
4/26
07:00 am
tech
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
Low
Report
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
4/24
12:17 pm
tech
Court Finds Advanced Cell Diagnostics Patents Invalid in Lawsuit with Molecular Instruments [Yahoo! Finance]
Low
Report
Court Finds Advanced Cell Diagnostics Patents Invalid in Lawsuit with Molecular Instruments [Yahoo! Finance]
4/24
11:23 am
tech
Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
Low
Report
Analysts Estimate Techne (TECH) to Report a Decline in Earnings: What to Look Out for [Yahoo! Finance]
4/24
04:29 am
tech
Global Market for Exosome Diagnostics, Therapeutics, and Research Tools (2021-2028) Featuring Bio-Techne, Exosomics, and System Biosciences - An Evaluation of New Commercial Opportunities and Emerging Trends [Yahoo! Finance]
Low
Report
Global Market for Exosome Diagnostics, Therapeutics, and Research Tools (2021-2028) Featuring Bio-Techne, Exosomics, and System Biosciences - An Evaluation of New Commercial Opportunities and Emerging Trends [Yahoo! Finance]
4/23
07:04 am
tech
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS [Yahoo! Finance]
Low
Report
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS [Yahoo! Finance]
4/23
07:00 am
tech
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
Low
Report
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
4/18
08:29 am
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $85.00 to $82.00. They now have a "buy" rating on the stock.
Medium
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $85.00 to $82.00. They now have a "buy" rating on the stock.
4/10
07:00 am
tech
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
Medium
Report
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
4/8
07:18 am
tech
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY [Yahoo! Finance]
Low
Report
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY [Yahoo! Finance]
4/8
07:00 am
tech
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
Low
Report
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
4/4
09:04 am
tech
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence [Seeking Alpha]
Neutral
Report
Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence [Seeking Alpha]